Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

David Woodward

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Guinea Pigs

Physiology

Anatomy

Concepts & Ideas

Drug Dose-Response Relationship

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
29
Krauss, Achim H-P
12
Burk, Robert
11
Chen, June
11
Wheeler, Larry
10
Gil, Daniel
10
Nieves, Amelia
9
Regan, John
8
Protzman, Charles
7
Pierce, Kristen
7
Liang, Yanbin
6
Kedzie, KM
6
Di Marzo, Vincenzo
6
Spada, Clayton
5
Senior, Judith
5
Tang-Liu, Diane D-S

Sign-in to see all Coauthors

Publications

TOP 3
Morera Enrico; De Petrocellis Luciano; Morera Ludovica; Moriello Aniello Schiano; Ligresti Alessia; Nalli Marianna; Woodward David F; Di Marzo Vincenzo; Ortar Giorgio
Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.
Woodward David F; Nilsson Siv F E; Toris Carol B; Kharlamb Alexander B; Nieves Amelia L; Krauss Achim H-P
Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow.
Fischer Deborah P; Hutchinson Jonathon A; Farrar Diane; O'Donovan Peter J; Woodward David F; Marshall Kay M
Loss of prostaglandin F2alpha, but not thromboxane, responsiveness in pregnant human myometrium during labour.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of David Woodward (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Morera Enrico; De Petrocellis Luciano; Morera Ludovica; Moriello Aniello Schiano; Ligresti Alessia; Nalli Marianna; Woodward David F; Di Marzo Vincenzo; Ortar Giorgio
Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.
Bioorganic & medicinal chemistry letters 2009;19(23):6806-9.
2009: Woodward David F; Nilsson Siv F E; Toris Carol B; Kharlamb Alexander B; Nieves Amelia L; Krauss Achim H-P
Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow.
Investigative ophthalmology & visual science 2009;50(7):3320-8.
2008: Fischer Deborah P; Hutchinson Jonathon A; Farrar Diane; O'Donovan Peter J; Woodward David F; Marshall Kay M
Loss of prostaglandin F2alpha, but not thromboxane, responsiveness in pregnant human myometrium during labour.
The Journal of endocrinology 2008;197(1):171-9.
2008: Woodward D F; Liang Y; Krauss A H-P
Prostamides (prostaglandin-ethanolamides) and their pharmacology.
British journal of pharmacology 2008;153(3):410-9.
2007: Ortar Giorgio; Cascio Maria Grazia; De Petrocellis Luciano; Morera Enrico; Rossi Francesca; Schiano-Moriello Aniello; Nalli Marianna; de Novellis Vito; Woodward David F; Maione Sabatino; Di Marzo Vincenzo
New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain.
Journal of medicinal chemistry 2007;50(26):6554-69.
2007: Wan Zhou; Woodward David F; Cornell Clive L; Fliri Hans G; Martos José L; Pettit Simon N; Wang Jenny W; Kharlamb Alexander B; Wheeler Larry A; Garst Michael E; Landsverk Kari J; Struble Craig S; Stamer W Daniel
Bimatoprost, prostamide activity, and conventional drainage.
Investigative ophthalmology & visual science 2007;48(9):4107-15.
2007: Burk Robert M; Woodward David F
A historical perspective and recent advances in prostamide research and therapeutics.
Current opinion in drug discovery & development 2007;10(4):413-21.
2007: Cantor Louis B; Hoop Joni; Wudunn Darrell; Yung Chi-Wah; Catoira Yara; Valluri Shailaja; Cortes Arnold; Acheampong Andrew; Woodward David F; Wheeler Larry A
Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract.
The British journal of ophthalmology 2007;91(5):629-32.
2007: Maione S; De Petrocellis L; de Novellis V; Moriello A Schiano; Petrosino S; Palazzo E; Rossi F Sca; Woodward D F; Di Marzo V
Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
British journal of pharmacology 2007;150(6):766-81.
2007: Woodward D F; Krauss A H; Wang J W; Protzman C E; Nieves A L; Liang Y; Donde Y; Burk R M; Landsverk K; Struble C
Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris.
British journal of pharmacology 2007;150(3):342-52.
2006: Matias I; Wang J W; Moriello A Schiano; Nieves A; Woodward D F; Di Marzo V
Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration.
Prostaglandins, leukotrienes, and essential fatty acids 2006;75(6):413-8.
2006: Nilsson Siv F E; Drecoll Enken; Lütjen-Drecoll Elke; Toris Carol B; Krauss Achim H-P; Kharlamb Alexander; Nieves Amelia; Guerra Teresa; Woodward David F
The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey.
Investigative ophthalmology & visual science 2006;47(9):4042-9.
2006: Griffiths A L; Marshall K M; Senior J; Fleming C; Woodward D F
Effect of the oestrous cycle, pregnancy and uterine region on the responsiveness of the isolated mouse uterus to prostaglandin F(2alpha) and the thromboxane mimetic U46619.
The Journal of endocrinology 2006;188(3):569-77.
2005: Yang Wu; Ni Jinsong; Woodward David F; Tang-Liu Diane D-S; Ling Kah-Hiing John
Enzymatic formation of prostamide F2alpha from anandamide involves a newly identified intermediate metabolite, prostamide H2.
Journal of lipid research 2005;46(12):2745-51.
2005: Chen June; Matias Isabel; Dinh Tim; Lu Ta; Venezia Sonia; Nieves Amelia; Woodward David F; Di Marzo Vincenzo
Finding of endocannabinoids in human eye tissues: implications for glaucoma.
Biochemical and biophysical research communications 2005;330(4):1062-7.
2005: Liang Yanbin; Li Chen; Guzman Victor M; Chang William W; Evinger Albert J; Sao Dyna; Woodward David F
Identification of a novel alternative splicing variant of RGS5 mRNA in human ocular tissues.
The FEBS journal 2005;272(3):791-9.
2005: Spada Clayton S; Krauss Achim H-P; Woodward David F; Chen June; Protzman Charles E; Nieves Amelia L; Wheeler Larry A; Scott David F; Sachs George
Bimatoprost and prostaglandin F(2 alpha) selectively stimulate intracellular calcium signaling in different cat iris sphincter cells.
Experimental eye research 2005;80(1):135-45.
2005: Chen June; Dinh Tim; Woodward David F; Holland Michael; Yuan Yang-Dar; Lin Tsung-Hua; Wheeler Larry A
Bimatoprost: mechanism of ocular surface hyperemia associated with topical therapy.
Cardiovascular drug reviews 2005;23(3):231-46.
2004: Liang Yanbin; Li Chen; Guzman Victor M; Chang William W; Evinger Albert J; Pablo Jozelyn V; Woodward David F
Upregulation of orphan nuclear receptor Nur77 following PGF(2alpha), Bimatoprost, and Butaprost treatments. Essential role of a protein kinase C pathway involved in EP(2) receptor activated Nur77 gene transcription.
British journal of pharmacology 2004;142(4):737-48.
2004: Woodward David F; Gil Daniel W
The inflow and outflow of anti-glaucoma drugs.
Trends in pharmacological sciences 2004;25(5):238-41.
2004: Smith-Thomas L; Moustafa M; Spada C S; Shi L; Dawson R A; Wagner M; Balafa C; Kedzie K M; Reagan J W; Krauss A H-P; Woodward D F; MacNeil S
Latanoprost-induced pigmentation in human iridial melanocytes is fibroblast dependent.
Experimental eye research 2004;78(5):973-85.
2004: Matias I; Chen J; De Petrocellis L; Bisogno T; Ligresti A; Fezza F; Krauss A H-P; Shi L; Protzman C E; Li C; Liang Y; Nieves A L; Kedzie K M; Burk R M; Di Marzo V; Woodward D F
Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism.
The Journal of pharmacology and experimental therapeutics 2004;309(2):745-57.
2004: Krauss Achim H-P; Woodward David F
Update on the mechanism of action of bimatoprost: a review and discussion of new evidence.
Survey of ophthalmology 2004;49 Suppl 1():S5-11.
2004: Woodward David F; Phelps R L; Krauss A H-P; Weber A; Short B; Chen J; Liang Y; Wheeler L A
Bimatoprost: a novel antiglaucoma agent.
Cardiovascular drug reviews 2004;22(2):103-20.
2003: Richter Markus; Krauss Achim H-P; Woodward David F; Lütjen-Drecoll Elke
Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide.
Investigative ophthalmology & visual science 2003;44(10):4419-26.
2003: Liang Yanbin; Li Chen; Guzman Victor M; Evinger Albert J; Protzman Charles E; Krauss Achim H-P; Woodward David F
Comparison of prostaglandin F2alpha, bimatoprost (prostamide), and butaprost (EP2 agonist) on Cyr61 and connective tissue growth factor gene expression.
The Journal of biological chemistry 2003;278(29):27267-77.
2003: Woodward D F; Krauss A H-P; Chen J; Liang Y; Li C; Protzman C E; Bogardus A; Chen R; Kedzie K M; Krauss H A; Gil D W; Kharlamb A; Wheeler L A; Babusis D; Welty D; Tang-Liu D D-S; Cherukury M; Andrews S W; Burk R M; Garst M E
Pharmacological characterization of a novel antiglaucoma agent, Bimatoprost (AGN 192024).
The Journal of pharmacology and experimental therapeutics 2003;305(2):772-85.
2002: Spada Clayton S; Nieves Amelia L; Woodward David F
Vascular activities of prostaglandins and selective prostanoid receptor agonists in human retinal microvessels.
Experimental eye research 2002;75(2):155-63.
2002: Burk Robert M; Woodward David F; Krauss Achim H P; Chen June; Protzmann Charles E; Williams Linda S; Chan Ming F
Ocular hypotensive activity of prostaglandin F2 alpha (PGF2 alpha) analogs with neutral substituents at position 1 is predicted by the isolated cat iris sphincter smooth muscle preparation but not Ca+ signalling in Swiss 3T3 cells.
Advances in experimental medicine and biology 2002;507():327-30.
2001: Smith-Thomas L C; Moustafa M; Dawson R A; Wagner M; Balafa C; Haycock J W; Krauss A H; Woodward D F; MacNeil S
Cellular and hormonal regulation of pigmentation in human ocular melanocytes.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2001;14(4):298-309.
2001: Spada C S; Nieves A L; Burke J A; Wheeler L A; Woodward D F
Differential effects of alpha-adrenoceptor agonists on human retinal microvessel diameter.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2001;17(3):255-77.
2001: Woodward D F; Krauss A H; Chen J; Lai R K; Spada C S; Burk R M; Andrews S W; Shi L; Liang Y; Kedzie K M; Chen R; Gil D W; Kharlamb A; Archeampong A; Ling J; Madhu C; Ni J; Rix P; Usansky J; Usansky H; Weber A; Welty D; Yang W; Tang-Liu D D; Garst M E; Brar B; Wheeler L A; Kaplan L J
The pharmacology of bimatoprost (Lumigan).
Survey of ophthalmology 2001;45 Suppl 4():S337-45.
2000: Schuster V L; Itoh S; Andrews S W; Burk R M; Chen J; Kedzie K M; Gil D W; Woodward D F
Synthetic modification of prostaglandin f(2alpha) indicates different structural determinants for binding to the prostaglandin F receptor versus the prostaglandin transporter.
Molecular pharmacology 2000;58(6):1511-6.
2000: Fujino H; Pierce K L; Srinivasan D; Protzman C E; Krauss A H; Woodward D F; Regan J W
Delayed reversal of shape change in cells expressing FP(B) prostanoid receptors. Possible role of receptor resensitization.
The Journal of biological chemistry 2000;275(38):29907-14.
2000: Woodward D F; Krauss A H; Chen J; Gil D W; Kedzie K M; Protzman C E; Shi L; Chen R; Krauss H A; Bogardus A; Dinh H T; Wheeler L A; Andrews S W; Burk R M; Gac T; Roof M B; Garst M E; Kaplan L J; Sachs G; Pierce K L; Regan J W; Ross R A; Chan M F
Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
British journal of pharmacology 2000;130(8):1933-43.
1998: Madhu C; Rix P; Nguyen T; Chien D S; Woodward D F; Tang-Liu D D
Penetration of natural prostaglandins and their ester prodrugs and analogs across human ocular tissues in vitro.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1998;14(5):389-99.
1998: Chen J; Woodward D F; Yuan Y D; Marshall K; Senior J
Prostanoid-induced contraction of the rabbit isolated uterus is mediated by FP receptors.
Prostaglandins & other lipid mediators 1998;55(5-6):387-94.
1997: Chien D S; Tang-Liu D D; Woodward D F
Ocular penetration and bioconversion of prostaglandin F2alpha prodrugs in rabbit cornea and conjunctiva.
Journal of pharmaceutical sciences 1997;86(10):1180-6.
1997: Krauss A H; Woodward D F; Burk R M; Gac T S; Gibson L L; Protzman C E; Abbass F; Marshall K; Senior J
Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1997;13(4):303-12.
1997: Krauss A H; Wiederholt M; Sturm A; Woodward D F
Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle.
Experimental eye research 1997;64(3):447-53.
1997: Woodward D F; Regan J W; Lake S; Ocklind A
The molecular biology and ocular distribution of prostanoid receptors.
Survey of ophthalmology 1997;41 Suppl 2():S15-21.
1997: Pierce K L; Bailey T J; Hoyer P B; Gil D W; Woodward D F; Regan J W
Cloning of a carboxyl-terminal isoform of the prostanoid FP receptor.
The Journal of biological chemistry 1997;272(2):883-7.
1997: Spada C S; Krauss A H; Nieves A L; Woodward D F
Effects of leukotrienes B4 (LTB4) and D4 (LTD4) on motility of isolated normodense human eosinophils and neutrophils.
Advances in experimental medicine and biology 1997;400B():699-706.
1997: Woodward D F; Fairbairn C E; Lawrence R A
Identification of the FP-receptor as a discrete entity by radioligand binding in biosystems that exhibit different functional rank orders of potency in response to prostanoids.
Advances in experimental medicine and biology 1997;400A():223-7.
1997: Abbas F; Amin Z; Burk R M; Krauss A H; Marshall K; Senior J; Woodward D F
A comparative study of thromboxane (TP) receptor mimetics and antagonists on isolated human umbilical artery and myometrium.
Advances in experimental medicine and biology 1997;407():219-30.
1996: Woodward D F; Chan M F; Cheng-Bennett A; Wheeler L A; Chen G; Burke J A; Kharlamb A; Lai R K; Shan T
In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.
Experimental eye research 1996;63(4):411-23.
1996: Woodward D F; Nieves A L; Friedlaender M H
Characterization of receptor subtypes involved in prostanoid-induced conjunctival pruritus and their role in mediating allergic conjunctival itching.
The Journal of pharmacology and experimental therapeutics 1996;279(1):137-42.
1996: Krauss A H; Woodward D F; Gibson L L; Protzman C E; Williams L S; Burk R M; Gac T S; Roof M B; Abbas F; Marshall K; Senior J
Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
British journal of pharmacology 1996;117(6):1171-80.
1995: Chen J; Champa-Rodriguez M L; Woodward D F
Identification of a prostanoid FP receptor population producing endothelium-dependent vasorelaxation in the rabbit jugular vein.
British journal of pharmacology 1995;116(7):3035-41.
1995: Woodward D F; Pepperl D J; Burkey T H; Regan J W
6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist.
Biochemical pharmacology 1995;50(10):1731-3.
1995: Graves P E; Pierce K L; Bailey T J; Rueda B R; Gil D W; Woodward D F; Yool A J; Hoyer P B; Regan J W
Cloning of a receptor for prostaglandin F2 alpha from the ovine corpus luteum.
Endocrinology 1995;136(8):3430-6.
1995: De Vries G W; Guarino P; McLaughlin A; Chen J; Andrews S; Woodward D F
An EP receptor with a novel pharmacological profile in the T-cell line Jurkat.
British journal of pharmacology 1995;115(7):1231-4.
1995: Pierce K L; Gil D W; Woodward D F; Regan J W
Cloning of human prostanoid receptors.
Trends in pharmacological sciences 1995;16(8):253-6.
1995: Woodward D F; Fairbairn C E; Krauss A H; Lawrence R A; Protzman C E
Radioligand binding analysis of receptor subtypes in two FP receptor preparations that exhibit different functional rank orders of potency in response to prostaglandins.
The Journal of pharmacology and experimental therapeutics 1995;273(1):285-7.
1995: Woodward D F; Nieves A L; Spada C S; Williams L S; Tuckett R P
Characterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen.
The Journal of pharmacology and experimental therapeutics 1995;272(2):758-65.
1995: Woodward D F; Bogardus A M; Donello J E; Fairbairn C E; Gil D W; Kedzie K M; Burke J A; Kharlamb A; Runde E; Andrews S W
Molecular characterization and ocular hypotensive properties of the prostanoid EP2 receptor.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1995;11(3):447-54.
1995: Woodward D F; Nieves A L; Hawley S B; Joseph R; Merlino G F; Spada C S
The pruritogenic and inflammatory effects of prostanoids in the conjunctiva.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1995;11(3):339-47.
1995: Krauss A H; Woodward D F; Chen J; Gibson L L; Lai R K; Protzman C E; Shan T; Williams L S; Gac T S; Burk R M
AGN 191976: a novel thromboxane A2-mimetic with ocular hypotensive properties.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 1995;11(3):203-12.
1994: Regan J W; Bailey T J; Pepperl D J; Pierce K L; Bogardus A M; Donello J E; Fairbairn C E; Kedzie K M; Woodward D F; Gil D W
Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
Molecular pharmacology 1994;46(2):213-20.
1994: Regan J W; Bailey T J; Donello J E; Pierce K L; Pepperl D J; Zhang D; Kedzie K M; Fairbairn C E; Bogardus A M; Woodward D F
Molecular cloning and expression of human EP3 receptors: evidence of three variants with differing carboxyl termini.
British journal of pharmacology 1994;112(2):377-85.
1994: Woodward D F; Lawrence R A
Identification of a single (FP) receptor associated with prostanoid-induced Ca2+ signals in Swiss 3T3 cells.
Biochemical pharmacology 1994;47(9):1567-74.
1994: Krauss A H; Nieves A L; Spada C S; Woodward D F
Determination of leukotriene effects on human neutrophil chemotaxis in vitro by differential assessment of cell motility and polarity.
Journal of leukocyte biology 1994;55(2):201-8.
1994: Spada C S; Nieves A L; Krauss A H; Woodward D F
Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro.
Journal of leukocyte biology 1994;55(2):183-91.
1994: Woodward D F; Chan M F; Burke J A; Cheng-Bennett A; Chen G; Fairbairn C E; Gac T; Garst M E; Gluchowski C; Kaplan L J
Studies on the ocular hypotensive effects of prostaglandin F2 alpha ester prodrugs and receptor selective prostaglandin analogs.
Journal of ocular pharmacology 1994;10(1):177-93.
1993: Woodward D F; Protzman C E; Krauss A H; Williams L S
Identification of 19 (R)-OH prostaglandin E2 as a selective prostanoid EP2-receptor agonist.
Prostaglandins 1993;46(4):371-83.
1993: Woodward D F; Lawrence R A; Fairbairn C E; Shan T; Williams L S
Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies.
Journal of lipid mediators 1993;6(1-3):545-53.
1993: Woodward D F; Spada C S; Hawley S B; Williams L S; Protzman C E; Nieves A L
Further studies on ocular responses to DP receptor stimulation.
European journal of pharmacology 1993;230(3):327-33.
1991: Krauss A H; Woodward D F
An atypical vasopermeability response to leukotrienes in the iris-ciliary body.
Prostaglandins 1991;41(6):559-70.
1991: Woodward D F; Krauss A H; Nieves A L; Spada C S
Studies on leukotriene D4 as an eosinophil chemoattractant.
Drugs under experimental and clinical research 1991;17(12):543-8.
1991: Woodward D F; Fairbairn C E; Goodrum D D; Krauss A H; Ralston T L; Williams L S
Ca2+ transients evoked by prostanoids in Swiss 3T3 cells suggest an FP-receptor mediated response.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21A():367-70.
1990: Protzman C E; Woodward D F
Prostanoid-induced blood-aqueous barrier breakdown in rabbits involves the EP2 receptor subtype.
Investigative ophthalmology & visual science 1990;31(11):2463-6.
1990: Woodward D F; Nieves A L; Williams L S
Thromboxane A2-mimetics are potent microvascular permeability factors in the conjunctiva.
The Journal of pharmacology and experimental therapeutics 1990;255(1):23-7.
1990: Cheng-Bennett A; Poyer J; Weinkam R J; Woodward D F
Lack of prostaglandin F2 alpha metabolism by human ocular tissues.
Investigative ophthalmology & visual science 1990;31(7):1389-93.
1990: Woodward D F; Hawley S B; Williams L S; Ralston T R; Protzman C E; Spada C S; Nieves A L
Studies on the ocular pharmacology of prostaglandin D2.
Investigative ophthalmology & visual science 1990;31(1):138-46.
1989: Woodward D F; Spada C S; Nieves A L; Hawley S B; Williams L S
Platelet-activating factor causes goblet cell depletion in the conjunctiva.
European journal of pharmacology 1989;168(1):23-30.
1989: Woodward D F; Burke J A; Williams L S; Palmer B P; Wheeler L A; Woldemussie E; Ruiz G; Chen J
Prostaglandin F2 alpha effects on intraocular pressure negatively correlate with FP-receptor stimulation.
Investigative ophthalmology & visual science 1989;30(8):1838-42.
1989: Woodward D F; Nieves A L; Williams L S; Gary R K; Wasserman M A; Gleason J G
Interactive effects of peptidoleukotrienes and histamine on microvascular permeability and their involvement in experimental cutaneous and conjunctival immediate hypersensitivity.
European journal of pharmacology 1989;164(2):323-33.
1989: Woodward D F; Gary R K; Spada C S; Hawley S B; Nieves A L
Time-dependent differences in the vasopermeability response to intradermal peptidoleukotrienes.
Journal of lipid mediators 1989;1(1):63-73.
1989: Woodward D F; Dowling M C; Chen J; Padillo E; Ruiz G
Sustained decreases in systemic blood pressure do not cause ocular hypotension.
Ophthalmic research 1989;21(1):37-43.
1988: Spada C S; Woodward D F; Hawley S B; Nieves A L; Williams L S; Feldmann B J
Synergistic effects of LTB4 and LTD4 on leukocyte emigration into the guinea pig conjunctiva.
The American journal of pathology 1988;130(2):354-68.
1988: Gary R K; Woodward D F; Nieves A L; Williams L S; Gleason J G; Wasserman M A
Characterization of the conjunctival vasopermeability response to leukotrienes and their involvement in immediate hypersensitivity.
Investigative ophthalmology & visual science 1988;29(1):119-26.
1987: Woodward D F; Novack G D; Williams L S; Nieves A L; Potter D E
Dihydrolevobunolol is a potent ocular beta-adrenoceptor antagonist.
Journal of ocular pharmacology 1987;3(1):11-5.
1986: Woodward D F; Spada C S; Hawley S B; Nieves A L
Conjunctival eosinophil infiltration evoked by histamine and immediate hypersensitivity. Modification by H1- and H2-receptor blockade.
Investigative ophthalmology & visual science 1986;27(10):1495-503.
1986: Woodward D F; Ledgard S E
Histamine-induced microvascular permeability increases in hamster skin: a response predominantly mediated by H2-receptors.
Agents and actions 1986;18(5-6):504-7.
1986: Spada C S; Woodward D F; Hawley S B; Nieves A L
Leukotrienes cause eosinophil emigration into conjunctival tissue.
Prostaglandins 1986;31(4):795-809.
1986: Woodward D F; Ledgard S E; Nieves A L
Conjunctival immediate hypersensitivity: re-evaluation of histamine involvement in the vasopermeability response.
Investigative ophthalmology & visual science 1986;27(1):57-63.
1986: Woodward D F; Johnson L; Spada C; Chen J
Effect of cimetidine and pyrilamine on histamine-induced ocular surface hyperemia.
Journal of ocular pharmacology 1986;2(3):275-8.
1985: Woodward D F; Spada C S; Hawley S B; Nieves A L
Histamine H1- and H2-receptor involvement in eosinophil infiltration and the microvascular changes associated with cutaneous anaphylaxis.
Agents and actions 1985;17(2):121-5.
1985: Woodward D F; Owen D A; Pipkin M A; Ledgard S E
Histamine involvement in the local and systemic microvascular effects produced by intradermal substance P.
Agents and actions 1985;17(2):126-30.
1985: Woodward D F; Ledgard S E
Effect of LTD4 on conjunctival vasopermeability and blood-aqueous barrier integrity.
Investigative ophthalmology & visual science 1985;26(4):481-5.
1985: Woodward D F; Ledgard S E
Comparison of leukotrienes as conjunctival microvascular permeability factors.
Ophthalmic research 1985;17(5):318-20.
1985: Woodward D F; Nieves A L
Topical anti-inflammatory activity of beta 2-adrenoceptor agonists in the conjunctiva.
Journal of ocular pharmacology 1985;1(4):391-6.
1984: Owen D A; Pipkin M A; Woodward D F
Studies on cutaneous vascular permeability in the rat: increases caused by histamine and histamine-like agents.
Agents and actions 1984;14(1):39-42.
1983: Weichman B M; Wasserman M A; Holden D A; Osborn R R; Woodward D F; Ku T W; Gleason J G
Antagonism of the pulmonary effects of the peptidoleukotrienes by a leukotriene D4 analog.
The Journal of pharmacology and experimental therapeutics 1983;227(3):700-5.
1983: Wasserman M A; Weichman B M; Woodward D F; Muccitelli R M; Gleason J G
Differentiation of the tracheal and lung parenchymal effects of synthetic leukotrienes in the guinea pig.
Advances in prostaglandin, thromboxane, and leukotriene research 1983;12():133-7.
1982: Woodward D F; Pipkin M A; Raval P; Owen D A
Effect of histamine H1- and H2-receptor antagonists, steroidal and non-steroidal anti-inflammatory agents on carrageenin-induced inflammation of the guinea-pig ear.
Archives internationales de pharmacodynamie et de thérapie 1982;257(2):295-306.
1981: Woodward D F; Raval P; Pipkin M A; Owen D A
Re-evaluation of the effect of non-steroidal anti-inflammatory agents on u.v.-induced cutaneous inflammation.
Agents and actions 1981;11(6-7):711-7.

Sign-in to see more